OakChart

CareCloud Inc

CCLDHealthcare·Health Information Services·USA·Micro·NASD·Nov 11 • 2:17 PM ET

2.630.00 (0.00%)
2026-11-11 20:18 CET
Market cap
111.90 USD m
Revenue, TTM
131.30 USD m
Net income, TTM
5.45 USD m
Free cash flow, TTM
21.61 USD m
EPS diluted, TTM
0.13
P/E
20.53
Compare

Price

CCLD against its 20, 50 and 200-day averages
2050200missearnings
2.002.503.001.7M3.4MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CCLDclose 2.6320-day 1.9550-day 2.02200-day 2.462.6352w low

31.0% under the 52-week high of 3.81 on 26 Mar 2026. 52-week low 1.67 on 3 Nov 2026. Last 15 sessions, 61.7% high to low

Profile

CCLD
52-week range, 45% of the way up
1.673.81

CareCloud, Inc. is a healthcare information technology company, which engages in the provision of an integrated suite of proprietary cloud-based electronic health records and practice management solutions. It operates through the Healthcare IT and Practice Management segments. The Healthcare IT segment offers a proprietary web-based suite of services such as practice management applications, certified electronic health records solutions, revenue cycle management services and mobile health applications. The Practice Management segment provides medical practices as well as telemedicine, management, bill-paying and financial advisory services. The company was founded by Mahmud Haq in 1999 and is headquartered in Somerset, NJ.

Employees3650
IPOJul 23, 2014
Beta1.48
ATR, 14d0.15
Rel volume1.53
Short float1.90%
Insider own15.72%
Inst own22.29%

Snapshot

6 groups

Valuation

Index-
Market Cap111.90M
Enterprise Value150.07M
Income5.45M
Sales131.30M
Book/sh0.53
Cash/sh0.11
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees3650
IPOJul 23, 2014

Ratios

P/E20.53
Forward P/E8.22
PEG0.15
P/S0.85
P/B4.95
P/C24.12
P/FCF5.18
EV/EBITDA4.97
EV/Sales1.14
Quick Ratio0.85
Current Ratio0.87
Debt/Eq1.89
LT Debt/Eq1.35
Option/ShortYes / Yes

Earnings

EPS (ttm)0.13
EPS next Y0.32
EPS next Q0.10
EPS this Y185.00%
EPS next Y12.28%
EPS next 5Y54.67%
EPS past 3/5Y- -
Sales past 3/5Y-4.61% 2.77%
EPS Y/Y TTM214.99%
Sales Y/Y TTM14.86%
EPS Q/Q146.25%
Sales Q/Q8.56%
EarningsNov 05 BMO
EPS/Sales Surpr.0.00% 0.67%

Ownership

Insider Own15.72%
Insider Trans0.00%
Inst Own22.29%
Inst Trans-8.65%
ROA10.87%
ROE24.02%
ROIC18.17%
Gross Margin35.68%
Oper. Margin10.02%
Profit Margin4.15%
SMA2035.01%
SMA5030.09%
SMA2007.10%
Trades-

Technical

Shs Outstand42.55M
Shs Float35.86M
Short Float1.90%
Short Ratio1.91
Short Interest0.68M
52W High3.81 -30.97%
52W Low1.67 57.49%
Volatility11.43% 6.75%
ATR (14)0.15
RSI (14)78.03
Beta1.48
Rel Volume1.53
Avg Volume355.11K
Volume407,097

Performance

Perf Week46.11%
Perf Month34.87%
Perf Quarter7.35%
Perf Half Y24.06%
Perf YTD-9.93%
Perf Year-20.54%
Perf 3Y122.88%
Perf 5Y-66.54%
Perf 10Y198.86%
Recom1.00
Target Price7.00
Prev Close2.63
Price2.63
Change %0.00%

Analyst ratings

latest 1 of 1
DateActionAnalystRating changeTargetImplied
Nov 13, 2024DowngradeRROTH MKMBuy → Neutral$5 → $3.50+33.1%

Peers

Mkt cap
TickerCompanyMkt cap
WAYWaystar Holding Corp5.54B
PHRPhreesia Inc791.71M
HCATHealth Catalyst Inc108.07M
DHDefinitive Healthcare Corp179.28M
HCTIHealthcare Triangle Inc3.87M
EVHEvolent Health Inc551.64M
HSTMHealthstream Inc889.60M
AMWLAmerican Well Corp209.14M
DOCSDoximity Inc5.96B

Insider trading

latest 14 of 17
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
BUSQUET ANNEDirectorAug 08 '26Option Exercise0.007,5000308,888Aug 10 09:30 PM
KORN BILLDirectorAug 08 '26Option Exercise0.007,5000225,383Aug 10 09:30 PM
MUNTER CAMERONDirectorAug 08 '26Option Exercise0.007,5000216,500Aug 10 09:30 PM
Sharnak Lawrence StevenDirectorAug 08 '26Option Exercise0.007,5000141,500Aug 10 09:30 PM
MUNTER CAMERONDirectorJul 31 '26Option Exercise0.006,2500209,000Jul 31 09:30 PM
KORN BILLDirectorJul 31 '26Option Exercise0.006,2500217,883Jul 31 09:30 PM
Sharnak Lawrence StevenDirectorJul 31 '26Option Exercise0.006,2500134,000Jul 31 09:30 PM
BUSQUET ANNEDirectorJul 31 '26Option Exercise0.006,2500301,388Jul 31 09:30 PM
Sharnak Lawrence StevenDirectorFeb 08 '26Option Exercise0.007,5000127,750Feb 10 09:30 PM
MUNTER CAMERONDirectorFeb 08 '26Option Exercise0.007,5000202,750Feb 10 09:30 PM
BUSQUET ANNEDirectorFeb 08 '26Option Exercise0.007,5000295,138Feb 10 09:30 PM
KORN BILLDirectorFeb 08 '26Option Exercise0.007,5000211,633Feb 10 09:30 PM
KORN BILLDirectorJan 31 '26Option Exercise0.006,2500204,133Feb 03 09:30 PM
BUSQUET ANNEDirectorJan 31 '26Option Exercise0.006,2500287,638Feb 03 09:30 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.44B
IWCiShares Micro-Cap ETFAUM: 1.22B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.23B

News

latest 14 of 100
  • CareCloud Accelerates Wound Care Expansion with New Clients, EHR Integration and Multimillion-Dollar Payer Client Audit Wins (GlobeNewswire)
  • CareCloud Posts Record Profits On Margin Gains, But Slowing Revenue And Unchanged Guidance Leave A Sold-Off Stock Unconvinced (Earnings Whispers) +20.00%
  • CareCloud Delivers Most Profitable Quarter in Company History: Record GAAP Net Income, Record GAAP EPS and Record adjusted EBITDA (GlobeNewswire)
  • CareCloud Must Prove Its Back-Half Ramp Is Real After A Bruising Quarter (Earnings Whispers)
  • CareCloud Appoints Mitchell Brie as Chief Compliance Officer to Support Compliance Services Growth (GlobeNewswire)
  • CareCloud to Announce Third Quarter 2026 Results on November 5, 2026 (GlobeNewswire) +9.04%
  • CareCloud Promotes Bonnie Boyer to Chief Financial Officer to Lead the Next Growth Phase (GlobeNewswire)
  • KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy (GlobeNewswire)
  • CareCloud Inc (CCLD) (Q2 2026) Earnings Call Highlights: Strategic Investments Drive Growth ... (GuruFocus.com) -8.66% +13.36%
  • CareCloud Reports Second Quarter 2026 Results (GlobeNewswire)
  • CareCloud to Announce Second Quarter 2026 Results on August 6, 2026 (GlobeNewswire)
  • Empower, a CareCloud Company, Helps Wound-Care Provider Reverse More Than $1 Million in Alleged Overpayments (GlobeNewswire)
  • CareCloud Shareholders Overwhelmingly Approve All Proposals, Reaffirming Confidence in Company Leadership and Strategy (GlobeNewswire)
  • CareCloud Acquires Empower Healthcare & Compliance Partners, adding a High-Growth Compliance Business to its AI-powered Platform (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.1000.1000.10033.7333.502
2026Q22026-08-060.0000.0230.00431.8831.853
2026Q12026-05-07-0.010-0.007-0.01031.2730.513
2025Q42026-03-120.0400.0400.03634.4232.093
2025Q32025-11-060.0400.0250.04031.0728.172
2025Q22025-08-050.0400.0100.03627.3826.692
2025Q12025-05-06-0.040-0.050-0.03627.6025.653
2024Q42025-03-130.000-0.0580.00128.2427.995
2024Q32024-11-12-0.040-0.137-0.04128.5528.544
2024Q22024-08-13-0.140-0.030-0.13928.1028.094
2024Q12024-05-14-0.020-0.290-0.01525.9626.044
2023Q42024-03-21-3.000-0.343-2.99928.4030.893
2023Q32023-11-02-0.420-0.332-0.42329.2830.435
2023Q22023-08-03-0.370-0.274-0.36829.3631.315
2023Q12023-05-04-0.280-0.297-0.28130.0030.886
2022Q42023-03-02-0.220-0.214-0.22032.5333.375

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY0.000-0.040-0.69031.8131.80
2018FY0.290-0.610-0.59450.5550.05
2019FY-0.600-0.554-0.60064.4464.82
2020FY-1.790-1.863-1.790105.12105.12
2021FY-0.770-0.918-0.771139.6139.26
2022FY-0.670-0.658-0.668138.83139.67
2023FY-4.110-1.413-4.107117.1119.52
2024FY-0.280-0.282-0.276110.84110.59
2025FY0.1000.0950.100120.5117.88
2026FY-0.285--129.44
2027FY-0.320--139.09
2028FY-0.370--141.51

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0520132.0831.5032.65
2026Q4S2026-09-1520033.8332.6535.00
2026Q4S2026-08-0630033.7932.6535.00
2026Q4S2026-07-2230033.7132.6534.76
2026Q4S2026-07-2130133.7132.6534.76
2026Q4S2026-05-2031133.7132.6534.76
2026Q4S2026-05-0831133.7232.6534.80
2026Q4S2026-05-0731134.1733.7234.80
2026Q4S2026-04-2030133.7033.3934.00
2026Q4S2026-04-1730133.7133.4034.00
2026Q4S2026-03-1230033.8333.4034.36
2026Q4S2026-01-2020033.5633.4033.72
2026Q4S2025-11-1121033.5633.4033.72
2026Q4S2025-11-1021033.5633.4033.72

Estimate history

EPS, annual-0.69-0.594-0.6-1.79-0.771-0.668-4.107-0.2760.1030.1281
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.0410.001-0.0360.0360.040.036-0.010.0040.099
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual31.81150.54664.439105.122139.599138.826117.059110.837120.499131.3
Period201720182019202020212022202320242025TTM
Sales, quarterly28.54628.23927.63227.37731.06734.42331.2731.8833.725
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual11.53111.8312.23813.3814.91715.22915.8816.25642.43842.549
Period201720182019202020212022202320242025MRQ
Shares, quarterly16.22216.25642.32142.32242.39742.43842.49342.49442.549
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue131.30120.50110.84117.06138.83139.60105.1264.4450.55
Cost of Goods Sold Incl. D&A84.4679.4274.9885.2296.1699.1174.7344.1934.11
Gross Profit46.8441.0835.8531.8442.6740.4930.4020.2516.44
Selling, General and Administrative Excl. Other33.6928.9726.0935.5637.1336.1036.0120.1818.66
Research and Development8.216.383.784.744.404.419.310.871.03
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income13.1512.129.76-3.725.534.38-5.610.07-2.22
Interest Expense2.690.290.901.190.410.460.490.380.35
Unusual Expense0.590.760.6443.39-1.080.852.660.000.32
Net Income Before Taxes10.0111.008.01-49.045.612.99-8.71-0.68-2.30
Income Taxes0.350.200.16-0.360.180.160.100.19-0.16
Consolidated Net Income9.6610.807.85-48.675.432.84-8.81-0.87-2.14
Net Income From Continuing Operations9.6610.807.85-48.675.432.84-8.81-0.87-2.14
Net Income5.453.89-4.46-64.35-10.09-11.22-22.69-7.26-6.96
EPS (Recurring)0.140.12-0.25-2.17-0.72-0.73-1.64-0.60-0.57
EPS (Basic, Before Extraordinaries)0.130.10-0.28-4.11-0.67-0.77-1.79-0.60-0.59
EPS (Diluted)0.130.10-0.28-4.11-0.67-0.77-1.79-0.60-0.59
EBITDA30.2228.8425.9012.8320.5520.157.184.960.63
Non-Operating Income (Expense)0.14-0.07-0.21-0.73-0.60-0.080.05-0.360.60
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.270.360.093.863.883.944.752.351.95
Price To Earnings Ratio20.5320.53-------
Price To Sales Ratio0.660.920.530.200.310.661.090.760.88
Gross Margin35.6834.0932.3527.2030.7329.0028.9131.4232.52
Operating Margin10.0210.058.81-3.183.993.14-5.340.10-4.40
Net Margin4.153.23-4.02-54.97-7.26-8.03-21.58-11.26-13.77
Shares Outstanding42.5542.4416.2615.8815.2314.9213.3812.2411.83
Market Capitalization111.90111.9059.5024.1342.7794.01119.6149.6145.01

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue33.7331.8831.2734.4231.0727.3827.6328.24
Cost of Goods Sold Incl. D&A19.8721.1920.8922.5120.2517.8618.8018.26
Gross Profit13.8510.6910.3811.9210.829.528.839.98
Selling, General and Administrative Excl. Other7.238.709.178.597.206.496.696.42
Research and Development1.052.192.422.541.581.021.241.01
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income6.621.991.223.323.623.032.153.56
Interest Expense1.800.810.060.010.150.070.060.07
Unusual Expense0.040.130.210.200.410.030.130.10
Net Income Before Taxes4.851.220.972.963.102.941.993.34
Income Taxes0.130.100.050.070.040.040.040.04
Consolidated Net Income4.731.120.922.893.062.901.953.30
Net Income From Continuing Operations4.731.120.922.893.062.901.953.30
Net Income4.190.18-0.441.521.701.54-0.860.01
EPS (Recurring)0.100.01-0.010.040.050.04-0.030.01
EPS (Basic, Before Extraordinaries)0.100.00-0.010.040.040.04-0.040.00
EPS (Diluted)0.100.00-0.010.040.040.04-0.040.00
EBITDA10.276.205.767.998.126.906.036.82
Non-Operating Income (Expense)0.080.180.03-0.150.040.020.03-0.05
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.050.050.050.120.070.090.090.24
Price To Earnings Ratio20.5320.8548.0971.74----
Price To Sales Ratio0.660.701.251.031.190.890.290.54
Gross Margin41.0733.5433.2034.6234.8334.7631.9635.34
Operating Margin19.636.253.899.6511.6511.077.7612.60
Net Margin12.420.57-1.424.425.465.61-3.120.04
Shares Outstanding42.5542.4942.4942.4442.4042.3242.3216.26
Market Capitalization111.9090.09155.10123.80135.8599.8858.8259.50

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments3.625.143.3312.3010.3420.9319.9914.474.36
Short Term Receivables18.7317.1116.9819.1721.7316.199.389.943.88
Inventories0.510.570.470.380.500.400.490.440.00
Other Current Assets2.891.972.462.802.987.301.141.220.69
Total Current Assets25.7424.8023.2434.6535.5644.8231.0026.078.93
Net Property, Plant & Equipment10.888.429.689.9812.3412.666.431.831.39
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets50.4137.8844.2690.7191.9679.2718.6119.2314.77
Deferred Tax Assets0.970.001.691.030.770.720.460.350.00
Other Assets0.570.510.640.840.981.250.360.490.44
Total Assets88.5671.6179.51137.21141.61138.7256.8747.9825.53
Short Term Debt Incl. Current Port. of LT Debt1.661.602.182.594.315.131.970.280.17
Accounts Payable6.944.575.805.685.956.463.492.440.99
Income Tax Payable---0.000.930.93---
Other Current Liabilities15.8313.4215.3214.1218.3716.515.715.443.16
Total Current Liabilities24.4219.5823.3022.4029.5629.0211.188.164.32
Long Term Debt2.631.8712.5511.2212.566.342.120.220.12
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.970.001.691.561.210.880.710.520.37
Other Liabilities1.040.390.260.340.341.230.020.210.46
Total Liabilities29.0621.8437.8035.5243.6837.4714.039.115.28
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.010.010.010.010.010.000.000.00
Common Equity59.5049.7741.71101.6897.93101.2442.8438.8720.25
Total Shareholders Equity59.5149.7741.72101.6997.93101.2542.8438.8720.25
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity59.5149.7741.72101.6997.93101.2542.8438.8720.25
Total Liabilities & Stockholders Equity88.5671.6179.51137.21141.61138.7256.8747.9825.53
Book Value Per Share1.403.062.636.686.567.573.503.291.76
Tangible Book Value Per Share0.210.73-0.160.720.401.641.981.660.47
Full-Time Employees3,6503,6503,6004,1504,1003,7002,7002,4001,700
Price to Book Ratio4.951.280.270.420.961.201.161.161.82
Return on Assets13.4810.39-44.923.902.02-9.01-1.66-5.82-20.48
Return on Equity19.7617.16-67.885.442.85-12.23-2.13-7.23-40.74
Return on Invested Capital17.3815.20-89.694.812.57-8.19-1.94-5.47-27.32
Quick Ratio1.031.240.981.531.191.532.733.142.07
Current Ratio1.051.271.001.551.201.542.773.202.07

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income9.6610.807.85-48.675.432.84-8.81-0.87-2.14
Depreciation17.1216.9816.4617.0415.6016.2513.024.962.91
Other Funds (Non Cash)2.481.160.8748.734.074.756.794.272.91
Funds from Operations29.3528.9325.1916.5725.1824.1210.928.443.48
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-4.35-0.37-4.55-1.11-4.03-10.79-11.81-0.823.34
Cash from Operating Activities25.0028.5620.6415.4621.1513.33-0.897.626.81
Capital Expenditures-7.28-8.03-7.41-11.61-11.77-10.56-7.75-2.56-1.03
Net Assets From Acquisitions0.000.000.000.000.00-12.58-23.72-1.60-12.60
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.00-0.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-1.44-16.510.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-8.71-24.54-7.41-11.61-11.77-23.15-31.47-4.16-13.63
Cash Dividends Paid-8.45-6.290.00-14.30-15.31-14.44-11.38-6.11-4.10
Change in Capital Stock-38.170.000.001.4310.869.1748.999.5922.82
Repurchase of Common Pref Stock-38.170.000.000.00-20.000.000.000.000.00
Sale of Common Pref Stock0.000.000.001.4330.879.1748.999.5922.82
Proceedsfrom Stock Options0.000.000.001.4330.872.7344.549.5922.82
Issuance or Reduction of Debt, Net30.590.83-10.681.11-1.006.88-0.67-0.43-0.46
Change in Long Term Debt30.590.83-10.681.11-1.006.88-0.67-0.43-0.46
Issuance of Long Term Debt51.2110.790.0014.700.0025.920.000.000.00
Reduction of Long Term Debt-20.62-9.96-10.68-13.59-1.00-19.05-0.67-0.43-0.46
Net Financing Active Other Cash Flow-0.75-0.15-0.58-1.52-2.20-2.12-3.52-1.62-0.59
Other Financing Activities Uses-0.75-0.15-0.58-1.52-2.20-2.12-3.52-1.62-0.59
Cash from Financing Activities-16.78-5.61-11.26-13.29-7.65-0.5233.421.4217.66
Exchange Rate Effect0.050.06-0.170.470.23-0.25-0.130.64-0.73
Net Change in Cash-0.44-1.531.81-8.971.96-10.590.935.5210.11
Free Cash Flow21.6123.7818.9512.4018.5610.41-3.485.065.78
Preferred Dividends (Cash Flow)--6.290.00-14.30-15.31-14.44-11.38-6.11-4.10
Price to Free Cash Flow6.596.343.12-13.07---26.48
Deferred Taxes & Investment Tax Credit-0.000.00-0.530.080.29-0.080.08-0.21

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments4.6413.393.853.625.0710.44
Short Term Receivables19.5917.5418.7418.7319.2817.52
Inventories0.510.470.430.510.600.52
Other Current Assets3.652.773.062.894.312.61
Total Current Assets28.3934.1826.0925.7429.2631.09
Net Property, Plant & Equipment12.0812.1212.1210.889.108.89
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets45.8946.7647.9450.4151.6734.70
Deferred Tax Assets---0.97--
Other Assets0.730.780.570.570.550.56
Total Assets87.1093.8586.7288.5690.5875.24
Short Term Debt Incl. Current Port. of LT Debt12.2712.332.101.661.251.52
Accounts Payable6.206.075.516.946.694.21
Other Current Liabilities14.1515.0915.8515.8315.2610.51
Total Current Liabilities32.6333.4923.4624.4223.2016.24
Long Term Debt30.5341.693.642.638.411.87
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.100.05-0.97--
Other Liabilities1.221.221.291.041.161.06
Total Liabilities64.4776.4528.3929.0632.7719.17
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity22.6217.4058.3359.5057.8056.07
Total Shareholders Equity22.6217.4058.3359.5157.8056.08
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity22.6217.4058.3359.5157.8056.08
Total Liabilities & Stockholders Equity87.1093.8586.7288.5690.5875.24
Book Value Per Share0.530.411.371.401.361.32
Tangible Book Value Per Share-0.55-0.690.240.210.140.50
Full-Time Employees---3,650--
Price to Book Ratio4.951.542.602.142.421.84
Return on Assets10.879.4512.1913.4813.9015.10
Return on Equity24.0221.7517.3719.7621.4922.69
Return on Invested Capital8.891.901.494.654.625.01
Quick Ratio0.851.011.091.031.241.88
Current Ratio0.871.021.111.051.261.91

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income4.731.120.922.893.062.90
Depreciation3.654.214.554.724.503.87
Other Funds (Non Cash)1.370.170.330.61-0.330.32
Funds from Operations9.795.545.798.227.237.09
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-4.141.53-2.180.450.130.32
Cash from Operating Activities5.647.073.618.687.377.41
Capital Expenditures-1.85-1.32-1.23-2.87-1.70-1.99
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-0.29-0.680.00-0.47-16.000.00
Other Sources0.000.000.000.00--
Cash from Investing Activities-2.14-2.01-1.23-3.33-17.70-1.99
Cash Dividends Paid-0.54-4.52-1.92-1.47-1.50-1.59
Preferred Dividends (Cash Flow)-0.54-4.52-1.92-1.47-1.50-1.59
Change in Capital Stock0.00-38.170.000.000.000.00
Repurchase of Common Pref Stock0.00-38.170.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-11.6747.73-0.18-5.296.48-0.17
Change in Long Term Debt-11.6747.73-0.18-5.296.48-0.17
Issuance of Long Term Debt0.0248.740.002.458.340.00
Reduction of Long Term Debt-11.68-1.01-0.18-7.74-1.87-0.17
Net Financing Active Other Cash Flow-0.06-0.56-0.06-0.07-0.05-0.00
Other Financing Activities Uses-0.06-0.56-0.06-0.07-0.05-0.00
Cash from Financing Activities-12.264.47-2.15-6.844.92-1.76
Exchange Rate Effect0.000.000.010.040.04-0.02
Net Change in Cash-8.769.540.24-1.46-5.373.63
Free Cash Flow5.326.553.206.556.506.25
Price to Free Cash Flow6.596.739.687.118.145.42

Revenue breakdown

United States2024: 110.84M 2025: 120.50M
Healthcare IT2024: 96.41M 2025: 106.57M
Medical Practice Management2024: 14.43M 2025: 13.93M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.90%0.7M35.9M316.74K
2026-10-151.83%0.7M35.8M313.88K
2026-09-301.82%0.7M35.8M310.97K
2026-09-151.69%0.6M35.8M315.26K
2026-08-311.51%0.5M35.8M322.02K
2026-08-141.17%0.4M35.8M335.30K
2026-07-311.28%0.5M35.8M408.26K
2026-07-151.29%0.5M35.9M446.57K
2026-06-301.13%0.4M35.9M516.33K
2026-06-150.88%0.3M35.9M615.95K
2026-05-291.11%0.4M35.9M651.92K
2026-05-151.54%0.6M35.9M612.14K
2026-04-301.43%0.5M35.9M517.92K
2026-04-151.51%0.5M35.9M503.32K
2026-03-311.60%0.6M35.9M437.32K
2026-03-132.19%0.8M35.9M333.94K
2026-02-271.58%0.6M35.8M295.98K
2026-02-131.53%0.5M35.8M316.72K
2026-01-301.46%0.5M35.8M351.21K
2026-01-151.57%0.6M35.8M351.91K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.100.250.171.0595190.000.638-0.0130.002
call5.000.000.050.002.8740.000.000.107-0.0120.001
call7.500.001.000.004.0320.000.000.085-0.0140.001
put2.500.000.200.403.7534.000.00-0.386-0.0250.002
put5.002.052.700.004.9050.000.00-0.893-0.0110.001
put7.504.405.400.007.6750.000.00-0.915-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-053Initial statement of beneficial ownership of securities2026-10-01SEC
2026-09-298-KCurrent report2026-09-28SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-08SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-08SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-08SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-08SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-244Statement of changes in beneficial ownership of securities2026-07-22SEC
2026-07-248-K/A2026-04-13SEC
2026-06-268-KCurrent report2026-06-25SEC
2026-06-09S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-058-KCurrent report2026-06-04SEC
2026-05-19FWPFiling under Securities Act Rule 163/433 of free writing prospectuses.SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-158-KCurrent report2026-05-15SEC
2026-05-1425-NSESEC
2026-05-1425-NSESEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-14424B5SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110051.15K1

Institutional holders

Manager% owned
VANGUARD CAPITAL MANAGEMENT LLC3.96%
Hillsdale Investment Management Inc.2.17%
DIMENSIONAL FUND ADVISORS LP1.57%
TWO SIGMA INVESTMENTS, LP1.36%
AMERICAN CENTURY COMPANIES INC1.20%
AMERIPRISE FINANCIAL INC1.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.96%
GEODE CAPITAL MANAGEMENT, LLC0.93%
WELLS FARGO & COMPANY/MN0.91%
GLOBEFLEX CAPITAL L P0.79%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.90%
Avantis U.S. Small Cap Value ETF1.11%
VANGUARD EXTENDED MARKET INDEX FUND0.95%
Fidelity Extended Market Index Fund0.44%
EA Bridgeway Omni Small-Cap Value ETF0.39%
1290 Essex Small Cap Growth Fund0.38%
Dimensional U.S. Small Cap ETF0.31%
iShares Micro-Cap ETF0.29%
Nationwide Bailard Small Cap Value Fund0.23%
Ultra-Small Company Fund0.22%

OakChart. CCLD. Cached 15 minutes.